Clinical trial
ANTI-TAC THERAPY FOR UVEITIS
NCT00001526 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001526 |
|---|---|
| Title | ANTI-TAC THERAPY FOR UVEITIS |
| Official title | Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis With Humanized Anti-Tac Antibody Therapy |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Uveitis |
| Intervention type | Drug |
| Interventions | Daclizumab (Zenapax) |
| Enrollment | 15 |
| Start date | Jun 4, 1996 |
| Completion | Sep 6, 2007 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: